Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2023 Earnings Call Transcript

Operator: Greetings. And welcome to Aurinia Pharmaceuticals Incorporated Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Related Keywords

Norway ,Switzerland ,Italy ,Germany ,Canada ,Finland ,Japan ,Austria ,Sweden ,Canadian ,Jamie Harrell ,Farzin Haque ,Joe Miller ,Maury Raycroft ,Stacy Ku ,Peter Greenleaf ,Justin Kim ,David Martin ,Ed Arce ,Jacqueline Lu ,Joseph Schwartz ,Toni Braxton ,American College Of Rheumatology ,Aurinia Alliance ,Exchange Commission ,Aurinia Pharmaceuticals Incorporated Second Quarter ,Nasdaq ,Aurinia Pharmaceuticals Inc ,Investor Relations For Aurinia Pharmaceuticals ,Aurinia Pharmaceuticals ,Call Transcript August ,Investor Relations ,Chief Executive Officer ,Chief Financial ,Get Uncomfortable ,Biopsy Sub Study ,Clinical Rheumatology ,American College ,Toni Braxton Get Uncomfortable ,